MRNA
Moderna, Inc.
79.00
USD
This page is just a preview of the data found in TrendSpider’s full version
Moderna, Inc. stock is up 4% since 30 days ago. The next earnings date is Feb 22, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 4 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 9 PUTs, 1 CALL. 50% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 29 Nov 17:59 | 19 Jan, 2024 | 85.00 | 4111 | ||
| 29 Nov 18:01 | 19 Jan, 2024 | 85.00 | 4111 | ||
| 29 Nov 18:02 | 19 Jan, 2024 | 85.00 | 4111 | ||
| 29 Nov 18:05 | 19 Jan, 2024 | 85.00 | 4111 | ||
| 29 Nov 18:21 | 17 Jan, 2025 | 120.00 | 962 | ||
| 29 Nov 18:21 | 17 Jan, 2025 | 120.00 | 962 | ||
| 29 Nov 18:22 | 17 Jan, 2025 | 120.00 | 962 | ||
| 29 Nov 18:33 | 19 Jan, 2024 | 85.00 | 4111 | ||
| 29 Nov 18:50 | 19 Jan, 2024 | 80.00 | 2795 | ||
| 29 Nov 20:18 | 19 Jan, 2024 | 70.00 | 601 |
Moderna, Inc. develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. The company has 44 development programs, which includes 26 in clinical trials across seven modalities.
